The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab in combination with chemotherapy for the treatment of Chinese patients (pts) with esophageal squamous cell carcinoma (ESCC): Results from one cohort of an ongoing phase 2 study.
 
Nong Xu
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Buhai Wang
No Relationships to Disclose
 
Yu-Xian Bai
No Relationships to Disclose
 
En Xiao Li
No Relationships to Disclose
 
Yanyan Li
Employment - BeiGene
 
Huanli Wang
Employment - BeiGene
 
Jianming Xu
No Relationships to Disclose